Adeptus Biotechnologies Corp. (ADPT) PT Raised to $27 at Morgan Stanley
Morgan Stanley analyst Kallum Titchmarsh raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $27.00 (from $22.00) while maintaining a Equalweight rating.